• en
  • fr
  • ro

Energy for a chance of living

Data lansarii:
October 01, 2013
EUR 375,000
Creating a Southern Regional Center for the deep diagnosis of blood cancers
2,500 anual blood tests vs. 700, 200 new cases monitored annually, applying European treatment protocols in a targeted manner, modeling cytostatics doses, bone marrow transplants
Improving the survival rates for adults and children with hemato-oncological diseases, improving the survival rate from 50%, the current value for Romania, to 80%, the European average.
Detaliile proiectului

The objective of the project called “Energy for a chance of living – Modernizing the Immunophenotyping and Molecular Citogenetics Laboratories within the Fundeni Clinical Institute of Bucharest”, that started in October 2013, in partnership with GDF SUEZ Energy Romania, is to create a Southern Regional Center for the deep diagnosis of blood cancers in children and adults, within the Fundeni Clinical Institute, with measurable and long-term effects.

The purpose of the €375,000 investment is to improve the survival rates for patients with hemato-oncological diseases. More specifically, we want to improve the survival rate from 50%, the current value in Romania, to 80%, the average European value.

Within the project, we are supporting the development of the diagnosis infrastructure, by purchasing two state-of-the-art pieces of equipment: an automated karyotyping system and an automated flow cytometry analyzer. The project also includes the renovation of laboratories and providing them with enough reactives needed for the blood tests to last them for at least 6 months.

Before the renovation, the physicians in Fundeni were working with 15-year-old equipment that didn’t allow deep diagnosis procedures according to international protocols. Around 700 tests were done annually, while the new equipment will give them the possibility of doing approximately 2,500. In addition, the minimal residual disease can now be tracked for about 200 new cases each year. This allows for the European treatment protocols to be applied in a targeted manner, by modeling the cytostatic doses and, in select cases, by doing a bone marrow transplant.



Share on FacebookTweet about this on Twitter